Log In
BCIQ
Print this Print this
 

AK156

  Manage Alerts
Collapse Summary General Information
Company Asahi Kasei Pharma Corp.
DescriptionOnce yearly zoledronic acid
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationOsteoporosis
Indication DetailsTreat osteoporosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today